Viewing Study NCT05976516



Ignite Creation Date: 2024-05-06 @ 7:20 PM
Last Modification Date: 2024-10-26 @ 3:05 PM
Study NCT ID: NCT05976516
Status: RECRUITING
Last Update Posted: 2023-08-04
First Post: 2023-02-19

Brief Title: CXCL2CXCL8 Promote Intervertebral Disc Degeneration
Sponsor: Zhongda Hospital
Organization: Zhongda Hospital

Study Overview

Official Title: Study on the Correlation Between CXCL2CXCL8 and the Degree of Intervertebral Disc Degeneration and Radiological Progress
Status: RECRUITING
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Low back pain LBP is the largest cause of morbidity in the world and about 80 of Chinese people are affected in their lifetime Although the prevalence of IDD gradually increases with age IDD is very common among subjects under 30 years old In addition to age there are other factors such as excessive or uneven mechanical load obesity genetics nutrition trauma and gender In addition it is not clear whether the heavy physical load associated with occupation is an important risk factor for IDD Some studies have found that IDD is more common among athletes than the general population Due to the complexity and multifactorial nature of IDD its pathogenesis and risk factors are still unclear which seriously hinders the rational stratification of LBP patients and limits the development of personalized treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None